Aims: to educate delegates on benefits of next generation sequencing (NGS) genotyping to identify
rare variants for NHS-reimbursed therapies, compassionate use programmes and trials enrolment.
All data will pertain to advanced NSCLC.
Chair: Professor Sanjay Popat
17:30 Introduction Sanjay Popat
17:31 BRAF, KRAS, & insertion mutations you need to know about Raffaele Califano
17:46 Splices and fusions you need to know about Alastair Greystoke
18:01 How will we find suitable patients? Rachel Butler
18:16 Q&A
18:30 Close